iRadimed Corporation - Common Stock (IRMD)
Frequently Asked Questions About iRadimed Corporation - Common Stock (IRMD)
Does iRadimed have a global presence?
Yes, while based in the United States, iRadimed Corporation has expanded its reach globally, supplying its products to various international markets and collaborating with partners to enhance its global footprint.
Has iRadimed received any awards or recognitions?
Yes, iRadimed Corporation has received several accolades for its innovative products and contributions to the healthcare field, particularly in enhancing patient safety and advancing MRI technology.
How can investors learn more about iRadimed?
Investors can learn more about iRadimed by visiting the company's official website, reviewing their financial reports and press releases, and following updates on financial news platforms that track publicly traded companies.
How does iRadimed ensure product quality?
iRadimed ensures product quality through rigorous testing, adherence to strict manufacturing standards, and compliance with regulatory requirements. Their commitment to quality management helps maintain high standards for safety and efficacy.
How has iRadimed performed financially?
iRadimed has shown positive growth in its financial performance over recent years, driven by increasing demand for its innovative MRI-compatible solutions, providing consistent revenue and expanding its market presence.
Is iRadimed publicly traded?
Yes, iRadimed Corporation is publicly traded on the Nasdaq stock exchange under the ticker symbol 'IRMD'.
What are the recent developments at iRadimed?
Recent developments at iRadimed have included the launch of new product lines, ongoing enhancements to existing technologies, and strategic partnerships aimed at expanding their market reach and ensuring cutting-edge advancements in MRI-safe medical devices.
What does iRadimed Corporation do?
iRadimed Corporation is a medical technology company that specializes in developing and manufacturing innovative MRI-compatible medical devices. The company is primarily known for its MRI-compatible infusers, which are used to safely deliver medications to patients undergoing magnetic resonance imaging (MRI) procedures.
What does iRadimed's stock performance look like?
iRadimed's stock performance has historically reflected the company's growth trajectory and innovation within the healthcare sector. Stock prices can fluctuate based on market conditions, company announcements, and overall industry trends.
What is iRadimed’s approach to research and development?
iRadimed places a strong emphasis on research and development, continually seeking to innovate and improve its product offerings to better meet the needs of healthcare providers and enhance patient safety in the MRI environment.
What is the company's mission?
The mission of iRadimed Corporation is to enhance patient care by providing innovative and safe solutions for MRI procedures. The company is dedicated to improving the healthcare experience through high-quality medical technology.
What is the growth potential for iRadimed?
The growth potential for iRadimed is significant, given the increasing prevalence of MRI procedures and the ongoing focus on patient safety in medical environments. The company's innovative products position it well to capture new market opportunities as healthcare evolves.
What makes iRadimed's products unique?
What sets iRadimed's products apart is their rigorous design and engineering tailored for compatibility with MRI environments. The MRI-compatible infusion systems provide reliable medication delivery without the risks traditionally associated with non-approved devices in the MRI space.
What markets does iRadimed serve?
iRadimed primarily serves the healthcare market, specifically focusing on hospitals and clinics that perform MRI imaging. Their products are designed to plug into the growing demand for MRI procedures and enhance the safety of patients during these imaging processes.
What products does iRadimed offer?
iRadimed offers a range of products including MRI-compatible infusion systems, patient monitoring equipment, and other solutions designed to enhance the quality of care in MRI environments. Their primary product, the MRI-compatible infusion pump, allows for medication delivery without compromising safety.
What regulatory approvals does iRadimed have?
iRadimed's products are subject to regulatory approvals from various health agencies, including the U.S. Food and Drug Administration (FDA) and international bodies, ensuring their safety and efficacy for use in medical settings.
When was iRadimed Corporation founded?
iRadimed Corporation was founded in 1982, establishing itself in the medical device industry with a focus on improving patient safety and comfort during MRI procedures.
Where is iRadimed Corporation headquartered?
iRadimed Corporation is headquartered in Winter Springs, Florida. This location serves as the central hub for its research, development, and manufacturing operations.
Who are iRadimed's competitors?
iRadimed faces competition from various medical device companies offering MRI-compatible systems and other medical technologies. Key competitors include companies that manufacture infusion systems and MRI equipment, all vying for a share in the expanding imaging market.
What is the current price of iRadimed Corporation - Common Stock?
The current price of iRadimed Corporation - Common Stock is 51.77
When was iRadimed Corporation - Common Stock last traded?
The last trade of iRadimed Corporation - Common Stock was at 4:00 pm EDT on April 17th, 2025
What is the market capitalization of iRadimed Corporation - Common Stock?
The market capitalization of iRadimed Corporation - Common Stock is 656.10M
How many shares of iRadimed Corporation - Common Stock are outstanding?
iRadimed Corporation - Common Stock has 12.67M shares outstanding.